Previous
Previous

Talking About Oxeia’s Phase 2 Clinical Trial for Concussion with Brain Injury Radio Host Kim Justus 

Next
Next

News Release: OXEIA BIOPHARMACEUTICALS ANNOUNCES NEW BOARD AND MANAGEMENT TEAM MEMBERS AND RELOCATES CORPORATE HEADQUARTERS TO BOSTON